摘要
冠心病被认为是一种炎症性疾病,抗炎治疗成为进一步降低冠心病剩余风险的希望。最近,针对冠心病不同抗炎通路的抗炎治疗又出现了几项大型心血管结局试验,并取得了一些有价值的结论。现就冠心病抗炎治疗通路研究现状及展望做一综述。
Coronary heart disease is considered as an inflammatory disease,and anti-inflammatory therapy has become a hope to further reduce the residual risk of coronary heart disease.Recently,there have been several large cardiovascular outcomes trials of anti-inflammatory therapy targeting different anti-inflammatory pathways in coronary heart disease,and some valuable conclusions have been obtained.This article reviews the status and prospect of anti-inflammatory therapeutic pathway for coronary heart disease.
作者
王大震
俞梦越
WANG Dazhen;YU Mengyue(Fuwai Hospital,Chinese Academy of Medical Sciences,Beijing 100037,China)
出处
《心血管病学进展》
CAS
2022年第7期586-589,599,共5页
Advances in Cardiovascular Diseases
关键词
抗炎通路
冠心病
抗炎治疗
Anti-inflammatory pathway
Coronary heart disease
Anti-inflammatory therapy